Clinical Trials
3 trialsNCT06175221 2025-09-15
Autologous TLPO Vaccine Basket
Elios Therapeutics, LLC
Phase 2 Terminated
NCT03630809 2022-04-25
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT02362451 2022-03-18
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated